StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
EPIGRAL.NS$1157.00-4.21%
Fair $1157.00+0.0%

EPIGRAL.NS

Epigral Limited

Basic Materials / ChemicalsNSE

$1157.00

-51.00 (-4.21%)

Fairly Valued+0.0%Fair Value $1157.00Fund rank 29/100 · Data gapFallback financials|
SA 48/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $413.8M · quality 56.0/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · EPIGRAL.NSLocal privado en este navegador · Epigral Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$49.9B

P/E

15.0x

↓

EV/EBITDA

10.0x

↓

ROE

14.9%

↑

Gross Margin

40.0%

↑

Debt/Equity

0.26

↑
52-Week Range$1157
$807$2114

TradingView lightweight chart

EPIGRAL.NS price, volumen y niveles de valoración

Último $1,161Periodo +185.6%
Fair value: $1,157

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+4.8%

FCF CAGR

-41.8%

FCF margin

1.7%

FCF / Net income

0.12x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $24.95B · net income $3.32B · FCF $413.8M

2023-FY → 2026-FY

Gross margin

40.0%-6.2% pts

Operating margin

16.0%-10.7% pts

Net margin

13.3%-3.0% pts

FCF margin

1.7%-8.0% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$24.95B$24.95B$25.14B$18.94B$21.69B
Net Income$3.32B$3.32B$3.58B$1.96B$3.53B
EBITDA$5.56B$5.56B$7.16B$4.77B$6.81B
EPS——84.6847.1485.03
Gross Margin40.0%40.0%44.0%41.1%46.2%
Operating Margin16.0%16.0%23.0%18.9%26.7%
Net Margin13.3%13.3%14.2%10.3%16.3%
Balance Sheet
Debt/Equity0.260.260.310.720.72
Current Ratio1.161.16———
Cash Flow
Free Cash Flow$413.8M$413.8M$2.46B$-8.0M$2.10B
Returns
ROE14.9%14.9%18.8%15.6%33.0%
Valuation
P/E15.0315.0320.8428.6511.42
EV/EBITDA10.0010.0011.2113.677.03
P/B2.252.253.914.473.77
Growth & Yield
Revenue Growth-0.8%-0.8%32.8%-12.7%—
EPS Growth——79.6%-44.6%—
Dividend Yield0.4%0.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -37.8%

Total return

-37.8%

Start / end P/E

n/dx → n/dx

EPS bridge

84.68 → n/d

Residual

-38.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.4%
Residual / FX / buybacks / cross-term-38.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.